Kiri

Dear All,

Could you please be so kind and respond for email below? We will be very grateful for your help.

Dear All,

We would like to ask you for clarification § 26(4) of Medical Devices Act which is as follows:

  (4) Any economic operator distributing on the Estonian market a system or procedure pack of medical devices pursuant to Article 2017 of Regulation (EU) 745/22 of the European Parliament and of the Council or Regulation (EU) 2017/745 of the European Parliament and of the Council or Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices (OJ L 189, 20.07.1990, p. 17–36) or Council Directive 93/42/EEC concerning medical devices (OJ L 169, 12.07.1993, pp. 1-43), a medical device classified according to risk class IIa, IIb or III, or an in vitro diagnostic medical device classified as class B, C or D in vitro diagnostic medical device in accordance with Annex VIII to Regulation (EU) 2017/746 of the European Parliament and of the Council, shall notify the Health Board thereof within ten days of the first distribution of the medical device concerned.

If an IVD (Class B, C, D) is distributed in Estonia by two entities: an Estonian distributor and by a distributor from outside Estonia – do both Distributors need to notify Estonian Agency about distributing this IVD on the Estonian market? Or does this product need to be notified once –only by the distributor who performed first distribution of the IVD on the Estonian market?

If it is sufficient that only one distributor notifies about the IVD, does the certificate issued according to the § 5 (2) of regulation Conditions for the notification of the making available on the market of a custom-made device and of any substantial modification thereto and of the distribution of a medical device cover the activity of the other distributor who did not perform the notification?

Thank you,

Emilia Adamczyk